Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational “LORENA” study

Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational “LORENA” study

Andrés Redondo,1 Manuel Ramos Vázquez,2 Luis Manso,3 Miguel J Gil Gil,4 Isabel Garau Llinas,5 Elisa García-Garre,6 César A Rodríguez,7 José Ignacio Chacón,8 Guillermo López-Vivanco9 1Clinical Oncology Department...

Full description

Bibliographic Details
Main Authors: Redondo A, Ramos Vázquez M, Manso L, Gil Gil MJ, Garau Llinas I, García-Garre E, Rodríguez CA, Chacón JI, López-Vivanco G
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:OncoTargets and Therapy
Subjects:
bevacizumab
metastatic breast cancer
real-world
maintenance hormonal therapy
taxane
Online Access:https://www.dovepress.com/long-term-response-to-first-line-bevacizumab-based-therapy-in-patients-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/long-term-response-to-first-line-bevacizumab-based-therapy-in-patients-peer-reviewed-article-OTT

Similar Items